US Stock MarketDetailed Quotes

NAYA NAYA Biosciences

Watchlist
  • 0.350
  • -0.010-2.81%
Close Feb 14 16:00 ET
  • 0.345
  • -0.005-1.29%
Post 17:05 ET
2.48MMarket Cap-0.35P/E (TTM)

NAYA Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.62%-640.81K
11.48%-1.46M
77.31%-260.56K
27.99%-4.76M
28.81%-714.88K
24.33%-1.25M
12.20%-1.64M
44.74%-1.15M
-9.51%-6.6M
33.55%-1M
Net income from continuing operations
-30.62%-1.63M
-0.21%-2.25M
37.41%-1.6M
26.24%-8.03M
27.91%-1.99M
51.03%-1.25M
20.03%-2.24M
8.05%-2.55M
-63.68%-10.89M
-2,952.08%-2.77M
Operating gains losses
235.32%27.37K
-622.15%-27.36K
1,924.73%561.56K
11.46%223.55K
2,013.04%191.44K
-61.98%8.16K
-103.21%-3.79K
-61.00%27.74K
19.08%200.56K
-104.68%-10.01K
Depreciation and amortization
1,024.15%230.5K
1,068.93%230.34K
1,089.08%226.96K
159.89%200.89K
610.12%141.6K
3.91%20.5K
156.60%19.71K
-73.65%19.09K
-53.46%77.3K
-74.87%19.94K
Other non cash items
-34.96%231.65K
76.47%295.97K
-78.29%48.49K
421.38%900.13K
56.56%152.87K
691.47%356.16K
--167.72K
--223.38K
-85.47%172.64K
-43.67%97.64K
Change In working capital
160.69%394.01K
-5,776.08%-809.55K
-53.26%285.11K
-68.17%471.7K
-52.77%524.67K
-309.72%-649.17K
-105.56%-13.78K
427.82%609.98K
141.10%1.48M
136.14%1.11M
-Change in receivables
100.38%159
-423.72%-80.32K
-60.99%-36.34K
-137.64%-63.4K
-307.14%-23.77K
-182.43%-41.87K
1,010.16%24.81K
-173.59%-22.57K
7.27%-26.68K
-860.16%-5.84K
-Change in inventory
-66.95%8.53K
280.11%16.39K
73.39%-1.95K
-103.74%-905
-162.24%-10.29K
1,283.27%25.8K
-172.01%-9.1K
-6.69%-7.32K
207.90%24.17K
531.60%16.53K
-Change in prepaid assets
-536.88%-41.45K
-12.55%-139.38K
-444.03%-330.1K
-566.88%-432.09K
-323.63%-257.07K
116.51%9.49K
-534.93%-123.84K
-211.19%-60.68K
174.15%92.55K
333.88%114.95K
-Change in payables and accrued expense
150.09%270.21K
-2,382.44%-517.32K
-29.26%546.52K
-35.24%822.53K
-40.41%610.25K
-342.37%-539.47K
-537.43%-20.84K
4,011.92%772.59K
840.71%1.27M
1,299.39%1.02M
-Change in other current liabilities
106.35%10.91K
942.61%7.76K
114.10%2.32K
-2,112.20%-141.38K
2,539.82%28.64K
-13,462.99%-171.85K
-98.74%744
101.99%1.09K
113.05%7.03K
103.31%1.09K
-Change in other working capital
111.91%145.66K
-184.48%-96.68K
243.11%104.66K
149.98%286.94K
543.44%176.9K
-55.97%68.73K
-39.29%114.44K
61.49%-73.13K
103.27%114.79K
98.63%-39.89K
Cash from discontinued investing activities
Operating cash flow
48.62%-640.81K
11.48%-1.46M
77.31%-260.56K
27.99%-4.76M
28.81%-714.88K
24.33%-1.25M
12.20%-1.64M
44.74%-1.15M
-9.51%-6.6M
33.55%-1M
Investing cash flow
Cash flow from continuing investing activities
0
98.04%-5.13K
-185.40%-24.11K
-2,971.87%-2.49M
287.86%33.29K
-74,973.70%-2.26M
-5,234.66%-261.51K
89.68%-8.45K
96.23%-81.22K
100.94%8.58K
Net PPE purchase and sale
--0
98.04%-5.13K
---24.11K
-4,023.52%-444.72K
-55,655.56%-75K
-4,091.21%-108.22K
-9,643.11%-261.51K
--0
97.41%-10.79K
-99.96%135
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
95.01%-1.94K
--0
Net business purchase and sale
--0
--0
--0
-2,893.41%-2.05M
1,181.84%108.29K
---2.15M
--0
88.79%-8.45K
95.97%-68.49K
100.58%8.45K
Cash from discontinued investing activities
Investing cash flow
--0
98.04%-5.13K
-185.40%-24.11K
-2,971.87%-2.49M
287.86%33.29K
-74,973.70%-2.26M
-5,234.66%-261.51K
89.68%-8.45K
96.23%-81.22K
100.94%8.58K
Financing cash flow
Cash flow from continuing financing activities
-96.19%169.46K
1,235.43%1.93M
-83.80%527.37K
578.31%7.39M
-117.69%-141.53K
17,753.12%4.45M
-169.86K
933.34%3.26M
-71.10%1.09M
-76.48%800K
Net issuance payments of debt
-97.80%31.96K
24.51%-143.55K
-94.97%27.37K
108.11%1.66M
-117.69%-141.53K
--1.45M
---190.15K
--544K
420.00%800K
--800K
Net common stock issuance
--0
713.61%165.13K
--0
1,867.55%5.7M
---23.05K
11,989.13%3M
--20.3K
759.89%2.71M
-92.06%289.8K
--0
Net preferred stock issuance
--137.5K
--1.01M
--500K
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--0
90,061,200.00%900.61K
--0
--25.43K
--23.05K
--0
---1
--2.38K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-96.19%169.46K
1,235.43%1.93M
-83.80%527.37K
578.31%7.39M
-117.69%-141.53K
17,753.12%4.45M
---169.86K
933.34%3.26M
-71.10%1.09M
-76.48%800K
Net cash flow
Beginning cash position
738.28%942.93K
-78.29%475.13K
157.86%232.42K
-98.41%90.14K
269.46%1.06M
-94.27%112.49K
-43.01%2.19M
-98.41%90.14K
-43.70%5.68M
-93.94%285.7K
Current changes in cash
-149.98%-471.34K
122.54%467.81K
-88.43%242.7K
102.54%142.29K
-320.90%-823.12K
156.25%943.06K
-10.55%-2.08M
213.72%2.1M
-26.78%-5.59M
-120.12%-195.56K
End cash Position
-55.32%471.59K
738.28%942.93K
-78.29%475.13K
157.86%232.42K
157.86%232.42K
269.46%1.06M
-94.27%112.49K
-43.01%2.19M
-98.41%90.14K
-98.41%90.14K
Free cash flow
52.73%-640.81K
20.73%-1.51M
72.99%-310.26K
21.41%-5.2M
21.33%-789.88K
17.91%-1.36M
-1.59%-1.91M
44.91%-1.15M
-2.03%-6.62M
15.13%-1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.62%-640.81K11.48%-1.46M77.31%-260.56K27.99%-4.76M28.81%-714.88K24.33%-1.25M12.20%-1.64M44.74%-1.15M-9.51%-6.6M33.55%-1M
Net income from continuing operations -30.62%-1.63M-0.21%-2.25M37.41%-1.6M26.24%-8.03M27.91%-1.99M51.03%-1.25M20.03%-2.24M8.05%-2.55M-63.68%-10.89M-2,952.08%-2.77M
Operating gains losses 235.32%27.37K-622.15%-27.36K1,924.73%561.56K11.46%223.55K2,013.04%191.44K-61.98%8.16K-103.21%-3.79K-61.00%27.74K19.08%200.56K-104.68%-10.01K
Depreciation and amortization 1,024.15%230.5K1,068.93%230.34K1,089.08%226.96K159.89%200.89K610.12%141.6K3.91%20.5K156.60%19.71K-73.65%19.09K-53.46%77.3K-74.87%19.94K
Other non cash items -34.96%231.65K76.47%295.97K-78.29%48.49K421.38%900.13K56.56%152.87K691.47%356.16K--167.72K--223.38K-85.47%172.64K-43.67%97.64K
Change In working capital 160.69%394.01K-5,776.08%-809.55K-53.26%285.11K-68.17%471.7K-52.77%524.67K-309.72%-649.17K-105.56%-13.78K427.82%609.98K141.10%1.48M136.14%1.11M
-Change in receivables 100.38%159-423.72%-80.32K-60.99%-36.34K-137.64%-63.4K-307.14%-23.77K-182.43%-41.87K1,010.16%24.81K-173.59%-22.57K7.27%-26.68K-860.16%-5.84K
-Change in inventory -66.95%8.53K280.11%16.39K73.39%-1.95K-103.74%-905-162.24%-10.29K1,283.27%25.8K-172.01%-9.1K-6.69%-7.32K207.90%24.17K531.60%16.53K
-Change in prepaid assets -536.88%-41.45K-12.55%-139.38K-444.03%-330.1K-566.88%-432.09K-323.63%-257.07K116.51%9.49K-534.93%-123.84K-211.19%-60.68K174.15%92.55K333.88%114.95K
-Change in payables and accrued expense 150.09%270.21K-2,382.44%-517.32K-29.26%546.52K-35.24%822.53K-40.41%610.25K-342.37%-539.47K-537.43%-20.84K4,011.92%772.59K840.71%1.27M1,299.39%1.02M
-Change in other current liabilities 106.35%10.91K942.61%7.76K114.10%2.32K-2,112.20%-141.38K2,539.82%28.64K-13,462.99%-171.85K-98.74%744101.99%1.09K113.05%7.03K103.31%1.09K
-Change in other working capital 111.91%145.66K-184.48%-96.68K243.11%104.66K149.98%286.94K543.44%176.9K-55.97%68.73K-39.29%114.44K61.49%-73.13K103.27%114.79K98.63%-39.89K
Cash from discontinued investing activities
Operating cash flow 48.62%-640.81K11.48%-1.46M77.31%-260.56K27.99%-4.76M28.81%-714.88K24.33%-1.25M12.20%-1.64M44.74%-1.15M-9.51%-6.6M33.55%-1M
Investing cash flow
Cash flow from continuing investing activities 098.04%-5.13K-185.40%-24.11K-2,971.87%-2.49M287.86%33.29K-74,973.70%-2.26M-5,234.66%-261.51K89.68%-8.45K96.23%-81.22K100.94%8.58K
Net PPE purchase and sale --098.04%-5.13K---24.11K-4,023.52%-444.72K-55,655.56%-75K-4,091.21%-108.22K-9,643.11%-261.51K--097.41%-10.79K-99.96%135
Net intangibles purchase and sale --------------0----------------95.01%-1.94K--0
Net business purchase and sale --0--0--0-2,893.41%-2.05M1,181.84%108.29K---2.15M--088.79%-8.45K95.97%-68.49K100.58%8.45K
Cash from discontinued investing activities
Investing cash flow --098.04%-5.13K-185.40%-24.11K-2,971.87%-2.49M287.86%33.29K-74,973.70%-2.26M-5,234.66%-261.51K89.68%-8.45K96.23%-81.22K100.94%8.58K
Financing cash flow
Cash flow from continuing financing activities -96.19%169.46K1,235.43%1.93M-83.80%527.37K578.31%7.39M-117.69%-141.53K17,753.12%4.45M-169.86K933.34%3.26M-71.10%1.09M-76.48%800K
Net issuance payments of debt -97.80%31.96K24.51%-143.55K-94.97%27.37K108.11%1.66M-117.69%-141.53K--1.45M---190.15K--544K420.00%800K--800K
Net common stock issuance --0713.61%165.13K--01,867.55%5.7M---23.05K11,989.13%3M--20.3K759.89%2.71M-92.06%289.8K--0
Net preferred stock issuance --137.5K--1.01M--500K----------0--0--0--------
Proceeds from stock option exercised by employees --090,061,200.00%900.61K--0--25.43K--23.05K--0---1--2.38K--0--0
Cash from discontinued financing activities
Financing cash flow -96.19%169.46K1,235.43%1.93M-83.80%527.37K578.31%7.39M-117.69%-141.53K17,753.12%4.45M---169.86K933.34%3.26M-71.10%1.09M-76.48%800K
Net cash flow
Beginning cash position 738.28%942.93K-78.29%475.13K157.86%232.42K-98.41%90.14K269.46%1.06M-94.27%112.49K-43.01%2.19M-98.41%90.14K-43.70%5.68M-93.94%285.7K
Current changes in cash -149.98%-471.34K122.54%467.81K-88.43%242.7K102.54%142.29K-320.90%-823.12K156.25%943.06K-10.55%-2.08M213.72%2.1M-26.78%-5.59M-120.12%-195.56K
End cash Position -55.32%471.59K738.28%942.93K-78.29%475.13K157.86%232.42K157.86%232.42K269.46%1.06M-94.27%112.49K-43.01%2.19M-98.41%90.14K-98.41%90.14K
Free cash flow 52.73%-640.81K20.73%-1.51M72.99%-310.26K21.41%-5.2M21.33%-789.88K17.91%-1.36M-1.59%-1.91M44.91%-1.15M-2.03%-6.62M15.13%-1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Trending Stocks

Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More